← Holders
KVP Capital Advisors, LP
What KVP Capital Advisors, LP reported holding on Form 13F for the quarter ended Sep 30, 2026.
CIK 1858198 · Filed Nov 16, 2026
- Positions
- 36
- Reported value
- $124.3M
- Opened
- 4
- Closed
- 3
- Other managers included
- 0
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
Quarters on file
- Dec 31, 2025$103.3M27 positions
- Mar 31, 2026$133.9M32 positions
- Jun 30, 2026$136.2M35 positions
- Sep 30, 2026$124.3M36 positions
| Security | Shares | Change | Value | Of portfolio |
|---|---|---|---|---|
PRAXPraxis Precision Medicines, Inc. | 42.9K | ±0% | $12.5M | 10.1% |
WHWKWhitehawk Therapeutics, Inc. | 2.2M | ±0% | $8.1M | 6.6% |
SLNSilence Therapeutics plc | 684.1K | New | $7.5M | 6% |
PTGXProtagonist Therapeutics, Inc | 53K | ±0% | $7.5M | 6% |
MBXMBX Biosciences, Inc. | 121.5K | ±0% | $7.1M | 5.7% |
ERASErasca, Inc. | 455K | ±0% | $6.7M | 5.4% |
TRVITrevi Therapeutics, Inc. | 414K | ±0% | $5.9M | 4.8% |
TNGXTango Therapeutics, Inc. | 230.3K | ±0% | $5.7M | 4.6% |
EWTXEdgewise Therapeutics, Inc. | 133K | ±0% | $5.4M | 4.3% |
TNDMTandem Diabetes Care Inc | 301K | ±0% | $4.9M | 3.9% |
ACHVAchieve Life Sciences, Inc. | 462.4K | ±0% | $3.7M | 3% |
STROSutro Biopharma, Inc. | 226.6K | ±0% | $3.7M | 2.9% |
INSMInsmed Inc | 28.5K | ±0% | $3.3M | 2.6% |
SVRASavara Inc | 605.3K | ±0% | $3.1M | 2.5% |
AVBPArriVent BioPharma, Inc. | 102K | ±0% | $3.1M | 2.5% |
IDYAIDEAYA Biosciences, Inc. | 79.7K | ±0% | $3.1M | 2.5% |
IRONDisc Medicine, Inc. | 43.8K | −24.9% | $2.9M | 2.3% |
UTHRUnited Therapeutics Corp | 4.8K | ±0% | $2.6M | 2.1% |
VRDNViridian Therapeutics, Inc. | 125K | ±0% | $2.6M | 2.1% |
IMMXImmix Biopharma, Inc. | 230.4K | ±0% | $2.4M | 1.9% |
DSGNDesign Therapeutics, Inc. | 185K | ±0% | $2.3M | 1.9% |
OCULOcular Therapeutix, Inc | 300K | ±0% | $2.3M | 1.9% |
TVTXTravere Therapeutics, Inc. | 39K | ±0% | $2.3M | 1.8% |
MLYSMineralys Therapeutics, Inc. | 84.2K | ±0% | $2.1M | 1.7% |
VOGXVogenx, Inc. | 86.1K | New | $2M | 1.6% |
NKTRNektar Therapeutics | 26.9K | ±0% | $1.6M | 1.3% |
DRUGBright Minds Biosciences Inc. | 31.8K | ±0% | $1.6M | 1.3% |
ZURAZura Bio Ltd | 373.1K | ±0% | $1.6M | 1.2% |
ARTVArtiva Biotherapeutics, Inc. | 200K | ±0% | $1.4M | 1.1% |
EOLSEvolus, Inc. | 150K | ±0% | $1.2M | 1% |
VERAVera Therapeutics, Inc. | 32.7K | ±0% | $1.1M | 0.8% |
CABACabaletta Bio, Inc. | 505.4K | ±0% | $970.4K | 0.8% |
ADILAzora Therapeutics, Inc. (DE) | 210.3K | New | $843.1K | 0.7% |
CMPXCompass Therapeutics, Inc. | 771K | ±0% | $801.8K | 0.6% |
CELCCelcuity Inc. | 4K | ±0% | $318.1K | 0.3% |
YARWYarrow Bioscience, Inc. | 10K | New | $225.4K | 0.2% |